Linda M. Rubinstein - 07 Jun 2023 Form 4 Insider Report for Adverum Biotechnologies, Inc. (ADVM)

Role
Chief Financial Officer
Signature
Linda Rubinstein, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
ADVM
Transactions as of
07 Jun 2023
Net transactions value
+$145,490
Form type
4
Filing time
09 Jun 2023, 16:26:47 UTC
Previous filing
15 Dec 2022
Next filing
05 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADVM Common Stock Purchase $145,490 +100,000 $1.45 100,000 07 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $1.38 to $1.53. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.